|
SLC25A46 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66559999961835E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.037900E-04 |
| Normal-vs-Stage2 |
1.399600E-01 |
| Normal-vs-Stage3 |
1.78887999999766E-05 |
| Normal-vs-Stage4 |
1.69729996724044E-09 |
| Stage1-vs-Stage2 |
8.101800E-01 |
| Stage1-vs-Stage3 |
7.459700E-02 |
| Stage1-vs-Stage4 |
6.175100E-04 |
| Stage2-vs-Stage3 |
1.772630E-01 |
| Stage2-vs-Stage4 |
2.957500E-02 |
| Stage3-vs-Stage4 |
1.828210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62779999998997E-06 |
| Normal-vs-AfricanAmerican |
1.0217999779627E-09 |
| Normal-vs-Asian |
3.421900E-02 |
| Caucasian-vs-AfricanAmerican |
4.245700E-04 |
| Caucasian-vs-Asian |
8.407200E-01 |
| AfricanAmerican-vs-Asian |
2.382400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22919999956395E-07 |
| Normal-vs-Female |
9.809500E-04 |
| Male-vs-Female |
2.583200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.797900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.996410E-04 |
| Normal-vs-Age(61-80Yrs) |
1.89490000002124E-06 |
| Normal-vs-Age(81-100Yrs) |
2.622300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.245000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.109200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.534000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.290000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.644040E-01 |
| Normal-vs-Grade 2 |
7.315700E-03 |
| Normal-vs-Grade 3 |
1.01370000005208E-06 |
| Normal-vs-Grade 4 |
8.90279960863438E-10 |
| Grade 1-vs-Grade 2 |
8.058200E-01 |
| Grade 1-vs-Grade 3 |
7.137600E-01 |
| Grade 1-vs-Grade 4 |
1.123840E-01 |
| Grade 2-vs-Grade 3 |
8.910400E-02 |
| Grade 2-vs-Grade 4 |
1.961820E-04 |
| Grade 3-vs-Grade 4 |
1.547640E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.951600E-01 |
| Normal-vs-ccB subtype |
2.43789999998523E-06 |
| ccA subtype-vs-ccB subtype |
1.035820E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.403800E-04 |
| Normal-vs-N1 |
2.256400E-02 |
| N0-vs-N1 |
1.932240E-01 |
|
|
